National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:48:44

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67457-255-10	ML - Milliliter	67457-255	52ce5ecc-7eb5-4cfc-bf5a-6de3df7b35b4	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
67457-255	67457-255-10

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	LEVETIRACETAM	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09
N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	LEVETIRACETAM	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09
N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	LEVETIRACETAM	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09
N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	LEVETIRACETAM	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N202543-001	AP
N202543-002	AP
N202543-003	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 166 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-001	LEVETIRACETAM IN SODIUM CHLORIDE	500MG/100ML (5MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-002	LEVETIRACETAM IN SODIUM CHLORIDE	1GM/100ML (10MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-003	LEVETIRACETAM IN SODIUM CHLORIDE	1.5GM/100ML (15MG/ML)	INJECTABLE / INTRAVENOUS	AP	RLD, RS	2011-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-004	LEVETIRACETAM IN SODIUM CHLORIDE	250MG/50ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	INJECTABLE / INTRAVENOUS		RLD	2020-12-14	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N202543-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202543-002	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202543-003	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N202543-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202543-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202543-003	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N202543-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202543-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202543-003	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202543-003	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202543-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202543-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202543-003	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202543-003	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202543-003	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202543-003	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202543-003	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202543-003	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202543-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202543-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202543-003	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N202543-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N202543-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N202543-003	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202543-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202543-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202543-003	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202543-001	AP	1	`301d65b070ca…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Levetiracetam	LEVETIRACETAM	Mylan Institutional LLC	70e52e89-3844-4cd9-a406-b29e9520a12c	2024-03-15	Warnings, Adverse reactions	Exact identifier ndc (package): 67457-255-10 ndc11 (package): 67457025510

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.